MoneyWorks4Me

Oxygenta Pharmaceutical informs about disclosure

27 Sep 2024 Evaluate
Oxygenta Pharmaceutical has informed that the exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pushpalatha Vustala.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1769.10
Dr. Reddys Labs. 1239.65
Cipla 1330.00
Lupin 1960.00
Zydus Lifesciences 1131.00
View more..